183 related articles for article (PubMed ID: 30295175)
21. Improving the Quality of Adeno-Associated Viral Vector Preparations: The Challenge of Product-Related Impurities.
Schnödt M; Büning H
Hum Gene Ther Methods; 2017 Jun; 28(3):101-108. PubMed ID: 28322595
[TBL] [Abstract][Full Text] [Related]
22. Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy.
Chandler RJ; LaFave MC; Varshney GK; Trivedi NS; Carrillo-Carrasco N; Senac JS; Wu W; Hoffmann V; Elkahloun AG; Burgess SM; Venditti CP
J Clin Invest; 2015 Feb; 125(2):870-80. PubMed ID: 25607839
[TBL] [Abstract][Full Text] [Related]
23. Vectrology of adeno-associated viruses (AAV).
Skubis-Zegadło J; Stachurska A; Małecki M
Med Wieku Rozwoj; 2013; 17(3):202-6. PubMed ID: 24296444
[TBL] [Abstract][Full Text] [Related]
24. Adeno-associated virus vector mediated gene transfer to pancreatic beta cells.
Prasad KM; Yang Z; Bleich D; Nadler JL
Gene Ther; 2000 Sep; 7(18):1553-61. PubMed ID: 11021593
[TBL] [Abstract][Full Text] [Related]
25. Gene therapy of the central nervous system: general considerations on viral vectors for gene transfer into the brain.
Serguera C; Bemelmans AP
Rev Neurol (Paris); 2014 Dec; 170(12):727-38. PubMed ID: 25459120
[TBL] [Abstract][Full Text] [Related]
26. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing.
Ulrich-Vinther M
Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340
[TBL] [Abstract][Full Text] [Related]
27. Adeno-Associated Virus Vectors and Stem Cells: Friends or Foes?
Brown N; Song L; Kollu NR; Hirsch ML
Hum Gene Ther; 2017 Jun; 28(6):450-463. PubMed ID: 28490211
[TBL] [Abstract][Full Text] [Related]
28. Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes.
Kalesnykas G; Kokki E; Alasaarela L; Lesch HP; Tuulos T; Kinnunen K; Uusitalo H; Airenne K; Yla-Herttuala S
Curr Gene Ther; 2017; 17(3):235-247. PubMed ID: 28982327
[TBL] [Abstract][Full Text] [Related]
29. Adeno-associated virus-mediated gene therapy in cardiovascular disease.
Hammoudi N; Ishikawa K; Hajjar RJ
Curr Opin Cardiol; 2015 May; 30(3):228-34. PubMed ID: 25783685
[TBL] [Abstract][Full Text] [Related]
30. Promise of adeno-associated virus as a gene therapy vector for cardiovascular diseases.
Bera A; Sen D
Heart Fail Rev; 2017 Nov; 22(6):795-823. PubMed ID: 28589503
[TBL] [Abstract][Full Text] [Related]
31. Current development of adeno-associated viral vectors.
Romano G
Drug News Perspect; 2005 Jun; 18(5):311-6. PubMed ID: 16193103
[TBL] [Abstract][Full Text] [Related]
32. [Developments in gene delivery vectors for ocular gene therapy].
Khabou H; Dalkara D
Med Sci (Paris); 2015 May; 31(5):529-37. PubMed ID: 26059304
[TBL] [Abstract][Full Text] [Related]
33. In Vivo Potency Assay for Adeno-Associated Virus-Based Gene Therapy Vectors Using AAVrh.10 as an Example.
De BP; Chen A; Salami CO; Van de Graaf B; Rosenberg JB; Pagovich OE; Sondhi D; Crystal RG; Kaminsky SM
Hum Gene Ther Methods; 2018 Jun; 29(3):146-155. PubMed ID: 29706115
[TBL] [Abstract][Full Text] [Related]
34. Transparenchymal Renal Pelvis Injection of Recombinant Adeno-Associated Virus Serotype 9 Vectors Is a Practical Approach for Gene Delivery in the Kidney.
Shen X; Xu Y; Bai Z; Ma D; Niu Q; Meng J; Fan S; Zhang L; Hao Z; Zhang X; Liang C
Hum Gene Ther Methods; 2018 Dec; 29(6):251-258. PubMed ID: 30458119
[TBL] [Abstract][Full Text] [Related]
35. Viral Vectors for Gene Transfer.
Chen YH; Keiser MS; Davidson BL
Curr Protoc Mouse Biol; 2018 Dec; 8(4):e58. PubMed ID: 30485696
[TBL] [Abstract][Full Text] [Related]
36. Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success--a personal perspective.
Hastie E; Samulski RJ
Hum Gene Ther; 2015 May; 26(5):257-65. PubMed ID: 25807962
[TBL] [Abstract][Full Text] [Related]
37. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
Janelidze S; Nordström U; Kügler S; Brundin P
J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
[TBL] [Abstract][Full Text] [Related]
38. Adeno-Associated Virus-Based Gene Therapy for CNS Diseases.
Hocquemiller M; Giersch L; Audrain M; Parker S; Cartier N
Hum Gene Ther; 2016 Jul; 27(7):478-96. PubMed ID: 27267688
[TBL] [Abstract][Full Text] [Related]
39. Adeno-associated viruses as liver-directed gene delivery vehicles: focus on lipoprotein metabolism.
Lagor WR; Johnston JC; Lock M; Vandenberghe LH; Rader DJ
Methods Mol Biol; 2013; 1027():273-307. PubMed ID: 23912992
[TBL] [Abstract][Full Text] [Related]
40. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
Saydam O; Glauser DL; Fraefel C
Cold Spring Harb Protoc; 2012 Mar; 2012(3):352-6. PubMed ID: 22383640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
